Coherus BioSciences Clinical Trials
Determine Coherus BioSciences Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
A sample of Coherus BioSciences Clinical Trials data
| Trial Title | Trial Identifier | Drug Name | Therapy Area | Indication | Trial Phase | Trial Status | Sponsor |
|---|---|---|---|---|---|---|---|
| Deserunt mollit sunt Lorem | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Pfizer Inc |
| A Randomized, Double-blind, Single-dose, Parallel-group Study to Assess the Pharmacokinetic Similarity of CHS-1420 DP and Humira (US) in Healthy Male and Female Subjects | GDCT0447945 | adalimumab biosimilar | Gastrointestinal; Immunology; Musculoskeletal Disorders | Ankylosing Spondylitis (Bekhterev's Disease); Crohn's Disease (Regional Enteritis); Plaque Psoriasis (Psoriasis Vulgaris); Polyarticular Juvenile Idiopathic Arthritis (PJIA); Psoriatic Arthritis; Rheumatoid Arthritis; Ulcerative Colitis | Phase I | Completed | Coherus BioSciences Inc |
| An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca (POEM) | GDCT0407325 | pegfilgrastim | Hematological Disorders | Febrile Neutropenia | Phase IV | Ongoing, recruiting | Coherus BioSciences Inc |
| A Three-way Pharmacokinetic (PK) Study of Avastin to Compare With the Innovent’s Biosimilar Bevacizumab | GDCT0388822 | bevacizumab | Oncology | Breast Cancer; Cervical Cancer; Colorectal Cancer; Epithelial Ovarian Cancer; Fallopian Tube Cancer; Glioblastoma Multiforme (GBM); Glioma; Lung Cancer; Malignant Glioma; Metastatic Breast Cancer; Metastatic Colorectal Cancer; Metastatic Hepatocellular Carcinoma (HCC); Metastatic Ovarian Cancer; Metastatic Renal Cell Carcinoma; Non-Small Cell Lung Cancer; Ovarian Cancer; Peritoneal Cancer; Recurrent Glioblastoma Multiforme (GBM); Recurrent Malignant Glioma ; Renal Cell Carcinoma | Phase I | Terminated | Coherus BioSciences Inc |
Feature
GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.
The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.
Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:
- 250+ clinical trial registries
- 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.
Benefit
The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).
Access:
- Detailed trial information.
- Drug information.
- Patient information, including inclusion and exclusion criteria.
- Trial results, as reported in the public domain.
- Biomarkers used for patient stratification/selection & outcome measures.
- Enrolment parameters.
- Investigators involved in clinical trials.
- Trials sites and locations.
- Contact information.
Value
Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.
Geographic Analysis - see where trials are being run.
Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.
Find information on trials contacts, as well as Site and Investigator information.
Get information on trial successes and failures.
Get intelligence on CROs engaged in clinical trials.
Use as a business development tool for CROs.
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer